Provenge Prostate Cancer Vaccine Can Prolong Patients Life
Provenge Prostate Cancer Vaccine could save the lives of patients with prostate cancer, for example, the results of a new study. The officials are planning to seek FDA approval of drugs.
Provenge, Dendreon Corp. through was to fight just for a second major test of the ability, against cancer. In the second study were 512 men with advanced prostate cancer treated with Provenge and the drug increased the survival rate.
Unlike other vaccines, Provenge will not prevent identifying cancer, but train the immune system and attack cancer cells. It is indeed a treatment instead of a preventive vaccine. If its the FDA the drug, the first of its kind on the market.
In a previous study of 127 men with advanced prostate cancer showed similar results Provenge, extending its duration of 4? Months. However, instruct the FDA approval because the drug has not been proven to slow the progression of cancer, but showed his ability to prolong life.
The technology used to make Provenge also prove useful against other cancers, researchers say.
Cancer advocates hope to convince that approve of this latest study by the FDA Provenge for the market. Based in Seattle Dender Corp., the FDA is planning to register or ask this year.
There are about 186 000 new cases of prostate cancer each year, according to the American Cancer Society. Among them are around 29,000 die from the disease. It is one of the most common cancer in American men after skin cancer.
Related posts:
- Prostate Cancer Prognosis Helps in Predicting the Future of the Disease Medical researchers have found prostate cancer drug that can cure...
- How Can Coffee Prevent Dangerous Prostate Cancer The coffee turned out to be a important advantage in...
Related posts brought to you by Yet Another Related Posts Plugin.
